Clinical Trial Update: A Phase IIa Study of KHK4563 [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase IIa study of KHK4563 in patients with uncontrolled and suspected eosinophilic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• KHK4563

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Uncontrolled and Suspected Eosinophilic Asthma | Phase 2 | Status: COMPLETED